MYNARIC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Mynaric AG and Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Mynaric AG for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Eastern District of New York on behalf of all individuals and entities who purchased Mynaric securities between June 20, 2024, and October 7, 2024 [1]. - Investors have until December 30, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Allegations Against Mynaric - The Complaint alleges that Mynaric's management made false and misleading statements about the company's business and operations [3]. - Specific issues cited include lower-than-expected production yields and component supplier shortages causing delays in the production of Mynaric's CONDOR Mk3 product [3]. - These production issues are expected to negatively impact the company's revenue growth and lead to an operating loss, making it unlikely for Mynaric to meet its previously issued financial guidance for FY 2024 [3]. - As a result, the company's business and financial prospects were overstated, rendering its public statements materially false and misleading [3].